SEARCH

SEARCH BY CITATION

References

  • 1
    Bullock BC, Paula R, Rudel LL. Dietary-induced cirrhosis in the pig-tailed macaque (Macaca nemestrina). Fed Proc 1974; 33: 626.
  • 2
    Lee SS, Ho KJ. Cholesterol fatty liver. Morphological changes in the course of its development in rabbits. Arch Pathol 1975; 99: 301306.
  • 3
    Gupta PP, Tandon HD, Ramalingaswami V. Cirrhosis of the liver in rabbits induced by a high cholesterol diet—an experimental model. Indian J Med Res 1976; 64: 15161526.
  • 4
    Ronnemaa T. Effect of high cholesterol, olive oil diet on the lipids and connective tissue in rat liver. A biochemical study. Scand J Gastroenterol 1976; 11: 849855.
  • 5
    Temmerman AM, Vonk RJ, Niezen-Koning K, Berger R, Fernandes J. Long-term and short-term effects of dietary cholesterol and fats in the Mongolian gerbil. Ann Nutr Metab 1988; 32: 177185.
  • 6
    Constantinides P, Gutmann-Auersperg N. Inhibition of progress of prees-tablished atherosclerosis by diethylstilbestrol in the rabbit. Arch Pathol 1960; 70: 3542.
  • 7
    Numano F, Katsu K, Kitta T, Shimamoto T. Banti-like syndrome induced by estrogen and cholesterol. Acta Hepatosplenol 1969; 16: 7785.
  • 8
    Skjaerlund JM. Estrogen protection against atherosclerosis and synthetic estrogen production of cirrhosis in the rabbit. Res Commun Chem Pathol Pharmacol 1992; 75: 193208.
  • 9
    Joist JH, Dolezel G, Kinlough-Rathbone R, Mustard JF. Effect of diet-induced hyperlipidemia on in vitro function of rabbit platelets. Thromb Res 1976; 9: 435445.
  • 10
    Peters JR, Elliott JM, Grahame-Smith DG. Effect of oral contraceptives on platelet noradrenaline and 5-hydroxytryptamine receptors and aggregation. Lancet 1979; 2: 933936.
  • 11
    Stuart MJ, Gerrard JM, White JG. Effect of cholesterol on production of thromboxane B2 by platelets in vitro. N Engl J Med 1980; 302: 610.
  • 12
    Anonymous. The coronary drug project: initial findings leading to modifications of its research protocol. JAMA 1970; 214: 13031313.
  • 13
    Suehiro A, Kakishita E, Nagai K. The role of platelet hyperfunction in thrombus formation in hyperlipidemia. Thromb Res 1982; 25: 331339.
  • 14
    Bremme K, Wramsby H, Andersson O, Wallin M, Blomback M. Do lowered factor VII levels at extremely high endogenous oestradiol levels protect against thrombin formation? Blood Coagul Fibrinolysis 1994; 5: 205210.
  • 15
    Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989; 84: 17861793.
  • 16
    Friedman SL. The cellular basis of hepatic fibrosis. N Engl J Med 1993; 328: 18281835.
  • 17
    Peterson TC, Isbrucker RA, Hooper ML. In vitro effect of platelet-derived growth factor on fibroproliferation and effect of cytokine antagonists. Immunopharmacology 1994; 28: 259270.
  • 18
    Wybenga DR, Pileggi VJ, Dirstine PH, DiGiorgio J. Direct manual determination of serum total cholesterol with a single stable reagent. Clin Chem 1970; 16: 980984.
  • 19
    Schwarz HP, Bergman K, Paumgartner G. A simple method for the estimation of bile acids in serum. Clin Chim Acta 1974; 50: 197206.
  • 20
    Rojkind M, Gonzales E. An improved method for determining specific radioactivities of proline-14C and hydroxyproline-14C in collagen and in noncollagenous proteins. Anal Biochem 1974; 57: 17.
  • 21
    Gascon-Barre M, Huet PM, Belgiorno J. Estimation of collagen content of liver specimens. Variation between animals and between hepatic lobes in cirrhotic rats. J Histochem Cytochem 1989; 37: 377381.
  • 22
    Lopez-DeLeon A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 1985; 3: 737743.
  • 23
    Mastai R, Laganiere S, Wanless IR, Giroux L, Rocheleau B, Huet P-M. Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit. 2. hemodynamic and drug disposition studies. Hepatology 1996; 24: 865870.
  • 24
    Wilson JD. The quantification of cholesterol excretion and degradation in the isotopic steady state in the rat: the influence of dietary cholesterol. J Lipid Res 1964; 5: 409417.
  • 25
    Hellstrom K. On the bile and neutral fecal steroid excretion in man and rabbits following cholesterol feeding. Acta Physiol Scand 1965; 63: 2135.
  • 26
    Quintao E, Grundy SM, Ahrens EHJ. Effects of dietary cholesterol on the regulation of total body cholesterol in man. J Lipid Res 1971; 12: 233247.
  • 27
    Forker EL. The effect of estrogen on bile formation in the rat. J Clin Invest 1969; 48: 654663.
  • 28
    Coe JE, Ishak KG, Ross MJ. Diethylstilbestrol-induced jaundice in the Chinese and Armenian hamster. Hepatology 1983; 3: 489496.
  • 29
    Tuchweber B, Perea A, Carrillo MC, Villalon L, Lemay J, Yousef IM. Low protein diet protects against ethinyl estradiol-induced cholestasis. Nutr Res 1994; 14: 707716.
  • 30
    Schaffher F, Popper H. Capillarization of the hepatic sinusoids in man. Gastroenterology 1963; 4: 239242.
  • 31
    Nanji AA, French SW. Relationship between pork consumption and cirrhosis. Lancet 1985; 1: 681683.
  • 32
    Patek AJ, Bowry S, Hayes KC. Cirrhosis of choline deficiency in the Rhesus monkey. Possible role of cholesterol. Proc Soc Exp Biol Med 1975; 148: 370374.
  • 33
    Hunt CE, Diani AR, Brown PK, Kaluzny MA, Epps DE. Diet induced atherogenic hyperlipoproteinaemia and liver injury in cynomolgus macaques. Br J Exp Pathol 1986; 67: 235249.
  • 34
    Phillips MJ, Poucell S, Patterson J, Valencia P. The liver: an atlas and text of ultrastructural pathology. New York, NY: Raven, 1987.
  • 35
    Davis RA, Kern F, Showalter R, Sutherland E, Sinensky M, Simon FR. Alterations of hepatic Na, K-ATPase and bile flow by estrogen: effects on liver surface membrane lipid structure and function. Proc Natl Acad Sci USA 1978; 75: 41304134.
  • 36
    Sweeney GD, Cole FM. Effects of ethynyl estradiol on liver microsomal mixed function oxygenase activity in male rats. Lab Invest 1980; 42: 231235.
  • 37
    Liehr JG, DaGue BB, Ballatore AM, Henkin J. Diethylstilbestrol (DES) quinone: a reactive intermediate in DES metabolism. Biochem Pharmacol 1983; 32: 37113718.
  • 38
    Peterson TC. Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor driven proliferation of fibroblasts. Hepatology 1993; 17: 486493.
  • 39
    Gressner AM, Bachem MG. Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases—liver fibrosis as a paradigm. Ann Biol Clin (Paris) 1994; 52: 205226.
  • 40
    Marra F, Choudhury GG, Pinzani M, Abboud HE. Regulation of platelet-derived growth factor secretion and gene expression in human liver fatstoring cells. Gastroenterology 1994; 107: 11101117.
  • 41
    Lane DA, Ireland H, Wolff S, Ranasinghe E, Dawes J. Detection of enhanced in vivo platelet alpha-granule release in different patient groups. Comparison of beta-thromboglobulin, platelet factor 4 and thrombospon-din assays. Thromb Haemost 1984; 52: 183187.
  • 42
    Hughes RD, Lane DA, Ireland H, Langley PG, Gimson AE, Williams R. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease. Clin Sci 1985; 68: 701707.
  • 43
    Goodman ZD, Ishak KG. Occlusive venous lesions in alcoholic liver disease: a study of 200 cases. Gastroenterology 1982; 83: 786796.
  • 44
    Burt AD, MacSween RN. Hepatic vein lesions in alcoholic liver disease: retrospective biopsy and necropsy study. J Clin Pathol 1986; 39: 6367.
  • 45
    Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology 1995; 21: 12381247.
  • 46
    Kelleher CC. Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: relation to the development of cardiovascular disease. Am J Obstet Gynecol 1990; 163: 392395.
  • 47
    Florentin RA, Nam SC, Lee KT, Thomas WA. Increased 3H-thymidine incorporation into endothelial cells of swine fed cholesterol for 3 days. Exp Mol Pathol 1969; 10: 250255.
  • 48
    Armstrong ML, Peterson RE, Hoak JC, Megan MB, Cheng FH, Clarke WR. Arterial platelet accumulation in experimental hypercholesterolemia. Atherosclerosis 1980; 36: 89100.
  • 49
    Wanless IR. The effect of dietary cholesterol on platelet survival in the rabbit. A study using 14C-serotonin and 51-Chromium double labelled platelets. Thromb Haemost 1984; 52: 8589.
  • 50
    Renaud S, Lecompte F. Hypercoagulability induced by hyperlipidemia in rat, rabbit and man. Role of platelet factor 3. Circ Res 1970; 27: 10031011.
  • 51
    Gresele P, Zoja C, Deckmyn H, Arnout J, Vermylen J, Verstraete M. Dipyridamole inhibits platelet aggregation in whole blood. Thromb Haemost 1983; 50: 852856.
  • 52
    Fahr A, Langer R, Sziegoliet W, Beitz J, Krause P, Forster W. In vivo synthesis of prostacyclin-like substances in human varicose veins. Biomed Biochem Acta 1984; 43: K6K8.
  • 53
    Dembinska-Kiec A, Rucker W, Schonhofer PS. Effects of dipyridamole in experimental atherosclerosis. Action on PGI2, platelet aggregation and atherosclerotic plaque formation. Atherosclerosis 1979; 33: 315327.
  • 54
    Lautt WW. Relationship between hepatic blood flow and overall metabolism: the hepatic arterial buffer response. Fed Proc 1983; 42: 16621666.
  • 55
    Kuwano H, Yano K, Ohno S, Ikebe M, Kitamura K, Toh Y, Mori M. et al. Dipyridamole inhibits early wound healing in rat skin incisions. J Surg Res 1994; 56: 267270.
  • 56
    Luliano L, Pratico D, Ghiselli A, Bonavita MS, Violi F. Reaction of dipyridamole with the hydroxyl radical. Lipids 1992; 27: 349353.
  • 57
    Jablonska-Kaszewska I, Dabrowska E, Boj E, Baranowska B, Vogel M. Effect of dipyridaniole on liver changes during acute poisoning with carbon tetrachloride in rats. Pol Arch Med Wewn 1979; 62: 511517.
  • 58
    Kast A, Nishikawa J, Yabe T. Decrease of carbon tetrachloride liver toxic-ity in rats given dipyridaniole. Exp Pathol 1982; 21: 123133.
  • 59
    Perezalvarez V, Bobadillalugo RA, Muriel P, Favari L, Villanuevalopez C. Effects of leukotriene synthesis inhibition on acute liver damage induced by carbon tetrachloride. Pharmacology 1993; 7: 330336.
  • 60
    Vissinger H, Husted SE, Kristensen SD, Nielsen HK. Dipyridaniole and platelet release of platelet-derived growth factor. Platelets 1994; 5: 105108.
  • 61
    Breddin HK. Current perspectives in the antiplatelet therapy of thrombotic disorders. Semin Thromb Hemost 1989; 15: 144149.
  • 62
    Suren A, Bauer FE, Rosenkranz B, Bircher J. Effect of pentoxifylline on liver plasma flow in normal man. Eur J Clin Pharmacol 1991; 41: 233237.
  • 63
    Crouch SPM, Fletcher J. Effect of ingested pentoxifylline on neutrophil superoxide anion production. Infect Immun 1992; 60: 45044509.
  • 64
    Shulman HM, Hinterberger W. Hepatic veno-occlusive disease—liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 197214.